Compare · LFMD vs OPCH
LFMD vs OPCH
Side-by-side comparison of LifeMD Inc. (LFMD) and Option Care Health Inc. (OPCH): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both LFMD and OPCH operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- OPCH is the larger of the two at $3.22B, about 14.6x LFMD ($220.5M).
- Over the past year, LFMD is down 60.5% and OPCH is down 35.9% - OPCH leads by 24.6 points.
- OPCH has been more active in the news (13 items in the past 4 weeks vs 5 for LFMD).
- OPCH has more recent analyst coverage (14 ratings vs 11 for LFMD).
- Company
- LifeMD Inc.
- Option Care Health Inc.
- Price
- $4.86+6.58%
- $20.07-2.14%
- Market cap
- $220.5M
- $3.22B
- 1M return
- -5.08%
- -5.73%
- 1Y return
- -60.50%
- -35.86%
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- News (4w)
- 5
- 13
- Recent ratings
- 11
- 14
LifeMD Inc.
LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for care across various indications, including concierge care, men's sexual health, dermatology, and others in the United States. The company provides ShapiroMD, a medical device for male and female hair loss; RexMD, a men's telehealth brand that offers virtual medical treatment from licensed providers for a variety of men's health needs; Nava MD, a female-oriented tele-dermatology and skincare brand that would offer virtual medical treatment from dermatologists and other providers; and iNR Wellness MD, a supplement for immune and digestive support. It also offers PDFSimpli, an online software-as-a-service platform that allows users to create, edit, convert, sign, and share PDF documents. LifeMD sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was founded in 1994 and is based in New York, New York.
Option Care Health Inc.
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides immunoglobulin infusion therapies for the treatment of immune deficiencies; anti-infective therapies and services; home infusion services to treat heart failures; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders; and immunoglobulin infusion therapies. It also offers infusion therapies for bleeding disorders; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications. In addition, the company offers therapies that women need to survive and thrive through high-risk pregnancies; treatments to manage the progression of neurological disorders, such as amyotrophic lateral sclerosis and duchenne muscular dystrophy; and nursing services. The company is headquartered in Bannockburn, Illinois.
Latest LFMD
- Chief Technology Officer Sripad Umesh was granted 75,000 shares (SEC Form 4)
- SEC Form 3 filed by new insider Sripad Umesh
- LifeMD Appoints Umesh Sripad as Chief Technology Officer
- LifeMD to Participate in Upcoming Investor Conferences
- Chief Financial Officer Kavthekar Atul was granted 337,500 shares (SEC Form 4)
- SEC Form 10-Q filed by LifeMD Inc.
- LifeMD Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
- SEC Form DEFA14A filed by LifeMD Inc.
- SEC Form DEFA14A filed by LifeMD Inc.
- SEC Form DEF 14A filed by LifeMD Inc.
Latest OPCH
- Option Care Health Appoints Robert Okunski as Vice President, Investor Relations
- Option Care Health Awarded TIME's World's Most Impactful Companies 2026 Ranking
- Director Bierbower Elizabeth D was granted 8,997 shares, increasing direct ownership by 38% to 32,871 units (SEC Form 4)
- Director Deckmann Natasha was granted 9,841 shares, increasing direct ownership by 44% to 32,002 units (SEC Form 4)
- Director Kraemer Harry M Jansen Jr was granted 21,076 shares, increasing direct ownership by 5% to 471,076 units (SEC Form 4)
- Director Pate R Carter was granted 8,997 shares, increasing direct ownership by 77% to 20,620 units (SEC Form 4)
- Director Sullivan Timothy P was granted 13,833 shares, increasing direct ownership by 19% to 87,216 units (SEC Form 4)
- Director Bodem Barbara W. was granted 8,997 shares, increasing direct ownership by 74% to 21,087 units (SEC Form 4)
- Director Wright Norman L. was granted 8,997 shares, increasing direct ownership by 58% to 24,498 units (SEC Form 4)
- Director Brandt Eric was granted 11,640 shares, increasing direct ownership by 112% to 21,999 units (SEC Form 4)